ArticleExperimental neurology2024

Pharmacological inhibition of receptor-interacting protein kinase 2 (RIPK2) elicits neuroprotective effects following experimental ischemic stroke.

Jonathan Larochelle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.